Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
Mortality and morbidity due to invasive fungal infections have increased over the years. Posaconazole is a second-generation triazole agent with an extended spectrum of activity, which shows a high interindividual variability in its plasma levels, rendering dosing in many patients inconsistent or in...
Main Authors: | Sarah Allegra, Giovanna Fatiguso, Silvia De Francia, Fabio Favata, Elisa Pirro, Chiara Carcieri, Amedeo De Nicolò, Jessica Cusato, Giovanni Di Perri, Antonio D’Avolio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/5/4/66 |
Similar Items
-
Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia
by: Camille Devanlay, et al.
Published: (2015-06-01) -
New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01) -
1,2,4-Triazol Yapısı Taşıyan Benzotiyazol Türevlerinin Sentezi ve Antifungal Aktiviteleri
by: Ulviye ACAR ÇEVİK, et al.
Published: (2020-01-01) -
Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital
by: Juan Vicente Mulet Bayona, et al.
Published: (2021-05-01) -
Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study
by: Weiyang Li, et al.
Published: (2020-03-01)